2021
DOI: 10.1111/apt.16493
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: topiramate for cyclic vomiting syndrome—for refractory patients only?

Abstract: LINKED CONTENTThis article is linked to Mooers et al papers. To view these articles, visit https://doi.org/10.1111/apt.16457 and https://doi.org/10.1111/apt.16516

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…
We thank Drs Rangan and Lembo for their insightful comments on our study on the effectiveness of topiramate as a prophylactic agent in cyclic vomiting syndrome (CVS). 1,2 Recent guidelines conditionally recommend that adults with moderate-to-severe CVS receive topiramate as an alternative prophylactic medication. 3 The guide-
…”
mentioning
confidence: 99%
“…
We thank Drs Rangan and Lembo for their insightful comments on our study on the effectiveness of topiramate as a prophylactic agent in cyclic vomiting syndrome (CVS). 1,2 Recent guidelines conditionally recommend that adults with moderate-to-severe CVS receive topiramate as an alternative prophylactic medication. 3 The guide-
…”
mentioning
confidence: 99%